CMV abundance in prostate epithelia increased with age, and CMV+ prostate cancer cells had higher levels of AR protein compared to uninfected cancer cells, findings that suggest that the effects of CMV we identified in vitro are operational also in humans in vivo. This evidence concerns the gene AR and Familial prostate cancer.